Flora Growth (FLGC) Competitors $19.77 +0.80 (+4.22%) Closing price 04:00 PM EasternExtended Trading$19.12 -0.65 (-3.29%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FLGC vs. LTRN, PDSB, AADI, MDCX, NBRV, SCYX, TELO, ESLA, IPSC, and RNXTShould you be buying Flora Growth stock or one of its competitors? The main competitors of Flora Growth include Lantern Pharma (LTRN), PDS Biotechnology (PDSB), Aadi Bioscience (AADI), Medicus Pharma (MDCX), Nabriva Therapeutics (NBRV), SCYNEXIS (SCYX), Telomir Pharmaceuticals (TELO), Estrella Immunopharma (ESLA), Century Therapeutics (IPSC), and RenovoRx (RNXT). These companies are all part of the "pharmaceutical products" industry. Flora Growth vs. Its Competitors Lantern Pharma PDS Biotechnology Aadi Bioscience Medicus Pharma Nabriva Therapeutics SCYNEXIS Telomir Pharmaceuticals Estrella Immunopharma Century Therapeutics RenovoRx Lantern Pharma (NASDAQ:LTRN) and Flora Growth (NASDAQ:FLGC) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations. Which has more volatility & risk, LTRN or FLGC? Lantern Pharma has a beta of 1.57, meaning that its stock price is 57% more volatile than the S&P 500. Comparatively, Flora Growth has a beta of 1.93, meaning that its stock price is 93% more volatile than the S&P 500. Do insiders and institutionals have more ownership in LTRN or FLGC? 28.6% of Lantern Pharma shares are held by institutional investors. Comparatively, 36.0% of Flora Growth shares are held by institutional investors. 8.5% of Lantern Pharma shares are held by insiders. Comparatively, 12.6% of Flora Growth shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor LTRN or FLGC? In the previous week, Flora Growth had 1 more articles in the media than Lantern Pharma. MarketBeat recorded 2 mentions for Flora Growth and 1 mentions for Lantern Pharma. Lantern Pharma's average media sentiment score of 0.00 beat Flora Growth's score of -0.30 indicating that Lantern Pharma is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lantern Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Flora Growth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer LTRN or FLGC? Lantern Pharma presently has a consensus price target of $25.00, suggesting a potential upside of 468.18%. Flora Growth has a consensus price target of $93.00, suggesting a potential upside of 370.41%. Given Lantern Pharma's higher possible upside, equities analysts clearly believe Lantern Pharma is more favorable than Flora Growth.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lantern Pharma 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Flora Growth 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Is LTRN or FLGC more profitable? Lantern Pharma has a net margin of 0.00% compared to Flora Growth's net margin of -24.86%. Lantern Pharma's return on equity of -99.89% beat Flora Growth's return on equity.Company Net Margins Return on Equity Return on Assets Lantern PharmaN/A -99.89% -81.58% Flora Growth -24.86%-261.57%-48.06% Which has stronger earnings & valuation, LTRN or FLGC? Flora Growth has higher revenue and earnings than Lantern Pharma. Lantern Pharma is trading at a lower price-to-earnings ratio than Flora Growth, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLantern PharmaN/AN/A-$20.78M-$1.78-2.47Flora Growth$59.51M0.24-$15.91M-$34.38-0.58 SummaryFlora Growth beats Lantern Pharma on 9 of the 14 factors compared between the two stocks. Get Flora Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGC vs. The Competition Export to ExcelMetricFlora GrowthMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.51M$10.59B$6.15B$10.62BDividend YieldN/A1.84%5.64%4.69%P/E RatioN/A22.2285.6627.13Price / Sales0.2435.30527.36205.87Price / CashN/A25.6126.3031.10Price / Book1.623.4812.926.67Net Income-$15.91M$210.63M$3.30B$276.23M7 Day Performance-10.70%2.52%4.80%3.31%1 Month Performance-12.54%2.31%8.11%10.76%1 Year Performance-67.50%-6.64%75.85%33.58% Flora Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGCFlora Growth2.3229 of 5 stars$19.77+4.2%$93.00+370.4%-68.8%$13.51M$59.51M-0.58280Short Interest ↑LTRNLantern Pharma2.0652 of 5 stars$4.54+2.0%$25.00+450.7%+9.0%$48.11MN/A-2.5520PDSBPDS Biotechnology1.7235 of 5 stars$1.01-1.0%$10.00+890.1%-72.5%$47.97MN/A-1.1020AADIAadi BioscienceN/A$1.94+2.6%N/A+1.0%$47.91M$25.07M-0.8540MDCXMedicus Pharma2.7475 of 5 stars$2.51-4.6%$23.50+836.3%N/A$46.86MN/A-1.87N/ANBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070SCYXSCYNEXIS0.563 of 5 stars$1.05-2.3%N/A-44.4%$45.07M$3.26M-2.6260News CoverageTELOTelomir Pharmaceuticals3.1167 of 5 stars$1.34-3.6%$15.00+1,019.4%-74.2%$44.87MN/A-2.481Positive NewsShort Interest ↓ESLAEstrella Immunopharma2.5509 of 5 stars$1.19-0.8%$16.00+1,244.5%+13.9%$44.48MN/A-4.58N/ANews CoveragePositive NewsGap UpIPSCCentury Therapeutics2.4771 of 5 stars$0.50-1.9%$3.75+650.6%-66.9%$43.98M$6.59M-1.72170News CoverageAnalyst DowngradeGap UpRNXTRenovoRx1.7809 of 5 stars$1.18flat$7.50+535.6%+29.4%$43.24M$662K-3.116Gap Up Related Companies and Tools Related Companies LTRN Competitors PDSB Competitors AADI Competitors MDCX Competitors NBRV Competitors SCYX Competitors TELO Competitors ESLA Competitors IPSC Competitors RNXT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGC) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A Millionaire With SEVEN Clicks? $1,000 in just seven stocks in 2004 could have turned into a million-dolla...The Oxford Club | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWarren Buffett’s #1 AI Stock is Not Even on the NasdaqNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flora Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flora Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
